Editorial Commentary
Dynamic tumor tracking for locally advanced pancreatic cancer: precision in motion
Translational Cancer Research
2026;
15
(6)
:440
.
(30 June 2026)
Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment
Translational Cancer Research
2026;
15
(6)
:441
.
(30 June 2026)
Do we need to adapt the American Joint Committee on Cancer staging system after neo-adjuvant treatment in esophageal squamous cell carcinoma?
Translational Cancer Research
2026;
15
(6)
:442
.
(30 June 2026)
Original Article
Complement system-related gene signatures implicated in the recurrence of glioma
Translational Cancer Research
2026;
15
(6)
:443
.
(30 June 2026)
The role of targeted therapy in the management of colorectal cancer liver metastases: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:444
.
(30 June 2026)
Global bibliometric analysis of TP53-mutated acute myeloid leukemia: research hotspots and evolution
Translational Cancer Research
2026;
15
(6)
:445
.
(30 June 2026)
Tumor histologic subtypes and stage impact the risk of cardiovascular diseases death in lung cancer patients after chemotherapy or radiotherapy: a population-based study
Translational Cancer Research
2026;
15
(6)
:446
.
(30 June 2026)
Bone morphogenetic protein 5 as a potential diagnostic and prognostic biomarker in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:447
.
(30 June 2026)
Recombinant adeno-associated virus-mediated HSV-TK/GCV gene therapy for ovarian cancer: an experimental study
Translational Cancer Research
2026;
15
(6)
:448
.
(30 June 2026)
METTL16-mediated upregulation of LINC00665 inhibits the apoptosis of breast cancer via regulating miR-28-5p/GLG1 axis
Translational Cancer Research
2026;
15
(6)
:449
.
(30 June 2026)
METTL3- and IGF2BP1-associated m6A regulation of FADS2 contributes to lipid droplet accumulation and malignant progression in non-small cell lung cancer
Translational Cancer Research
2026;
15
(6)
:450
.
(30 June 2026)
DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation
Translational Cancer Research
2026;
15
(6)
:451
.
(30 June 2026)
LINC01614 favors breast cancer progression through the regulation of miR-217/FN1 and mediation in PI3K/AKT signal pathway
Translational Cancer Research
2026;
15
(6)
:452
.
(30 June 2026)
A LASSO-based nomogram for predicting breast cancer-specific survival in elderly patients after surgery: a large retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:453
.
(30 June 2026)
CSN3 promotes gastric cancer progression and is associated with immune infiltration and inflammatory signaling
Translational Cancer Research
2026;
15
(6)
:454
.
(30 June 2026)
Construction of a ferroptosis-related prognostic signature and identification of SRSF9 as a key biomarker in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:455
.
(30 June 2026)
Combinatorial post-translational modification reprogramming of the endomembrane system in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:456
.
(30 June 2026)
Treatment strategies and survival outcomes of vestibular schwannoma: a comparative study based on Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2026;
15
(6)
:457
.
(30 June 2026)
Development and validation of a DYX1C1- and GNAI1-based nomogram for predicting relapse in HER2-positive breast cancer treated with trastuzumab
Translational Cancer Research
2026;
15
(6)
:458
.
(30 June 2026)
CLCA1 as an immune prognostic biomarker and therapeutic target in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:459
.
(30 June 2026)
Development and validation of an interpretable model based on ultrasound radiomics for predicting Ki-67 expression levels in breast cancer
Translational Cancer Research
2026;
15
(6)
:460
.
(30 June 2026)
Artificial intelligence-based models for colorectal cancer diagnosis using laboratory tests: an exploratory retrospective case-control study
Translational Cancer Research
2026;
15
(6)
:461
.
(30 June 2026)
Effects of different drugs on radiation-induced oral mucositis in patients with head and neck tumors: a systematic review and a network meta-analysis
Translational Cancer Research
2026;
15
(6)
:462
.
(30 June 2026)
Identification of GADD45B, HMGB3, LMNB2, and MFAP5 as lactylation-related prognostic markers for survival prediction in esophageal cancer
Translational Cancer Research
2026;
15
(6)
:463
.
(30 June 2026)
Development and internal validation of a SEER-based prediction model for survival in poorly and undifferentiated colorectal neuroendocrine neoplasms
Translational Cancer Research
2026;
15
(6)
:464
.
(30 June 2026)
Ailanthone as a novel AKT1 inhibitor that induces mitochondrial apoptosis and exerts anti-tumor activity in cervical cancer
Translational Cancer Research
2026;
15
(6)
:465
.
(30 June 2026)
Si Ni Powder enhances chemotherapy efficacy in sleep-deprived breast cancer via modulation of the tumor microenvironment
Translational Cancer Research
2026;
15
(6)
:466
.
(30 June 2026)
Development and validation of a Random Forest prediction model integrating clinical and ultrasound radiomics features for microvascular invasion in hepatocellular carcinoma patients: a retrospective study
Translational Cancer Research
2026;
15
(6)
:467
.
(30 June 2026)
The prognostic value of log odds of positive lymph nodes in patients with resectable locally advanced gastric cancer following neoadjuvant therapy: results from the SEER database
Translational Cancer Research
2026;
15
(6)
:468
.
(30 June 2026)
Integrative bioinformatics and experimental analysis identify S100A10 as a diagnostic and prognostic biomarker in pancreatic adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:469
.
(30 June 2026)
WAC is associated with malignant phenotypes and Wnt/β-catenin pathway activity in liver cancer cells
Translational Cancer Research
2026;
15
(6)
:470
.
(30 June 2026)
Endoplasmic reticulum stress promotes colorectal cancer proliferation by regulating autophagy via XBP1s
Translational Cancer Research
2026;
15
(6)
:471
.
(30 June 2026)
Phase separation of MARCH1 promotes rectal adenocarcinoma progression through PHLPP2 ubiquitination
Translational Cancer Research
2026;
15
(6)
:472
.
(30 June 2026)
SDF4: a novel prognostic biomarker and therapeutic target in hepatocellular carcinoma revealed by integrated multi‑omics analysis
Translational Cancer Research
2026;
15
(6)
:473
.
(30 June 2026)
KLK6 regulates ferroptosis through YAP/TAZ in lung adenocarcinoma
Translational Cancer Research
2026;
15
(6)
:474
.
(30 June 2026)
Survival improvement and widening social disadvantage-related disparities in osteosarcoma: a Surveillance, Epidemiology, and End Results-based retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:475
.
(30 June 2026)
Divergent roles of PRR11 and HEPACAM in pleural mesothelioma: PRR11 as a prognostic biomarker and HEPACAM as a stage-associated gene with paradoxical expression
Translational Cancer Research
2026;
15
(6)
:476
.
(30 June 2026)
Identification of telomere-related gene signatures for immune cell infiltration and prognosis in hepatocellular carcinoma
Translational Cancer Research
2026;
15
(6)
:477
.
(30 June 2026)
Identification of exhausted CD8+ T-cell signatures for prognosis in multiple myeloma by integrated analysis of single-cell and bulk RNA-sequencing
Translational Cancer Research
2026;
15
(6)
:478
.
(30 June 2026)
The evolving landscape of early diagnosis for hepatocellular carcinoma: a bibliometric analysis of global research trends (2016–2026) based on WoSCC database
Translational Cancer Research
2026;
15
(6)
:479
.
(30 June 2026)
Integrated multi-omics analysis reveals tumor-suppressive phenotypes and associated transcriptomic remodeling upon METTL3 overexpression in A549 lung cancer cells
Translational Cancer Research
2026;
15
(6)
:480
.
(30 June 2026)
Prognostic and therapeutic implications of PSMD14 in hepatocellular carcinoma: an integrative analysis of transcriptomic and single-cell profiles
Translational Cancer Research
2026;
15
(6)
:481
.
(30 June 2026)
A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma
Translational Cancer Research
2026;
15
(6)
:482
.
(30 June 2026)
A pan-cancer functional atlas of ADH1A reveals its conserved role in the tumor microenvironment and immunity
Translational Cancer Research
2026;
15
(6)
:483
.
(30 June 2026)
A stromal-derived five-gene signature predicts gastric cancer recurrence through integrated bioinformatics and single-cell analysis
Translational Cancer Research
2026;
15
(6)
:484
.
(30 June 2026)
Risk factors for short-term survival in EGFR-mutated non-small cell lung cancer with brain metastasis and prognosis of the leptomeningeal metastasis subgroup: a retrospective cohort study
Translational Cancer Research
2026;
15
(6)
:485
.
(30 June 2026)
Potential role of PPARGC1A in linking ulcerative colitis to colorectal cancer: a novel prognostic biomarker and therapeutic target
Translational Cancer Research
2026;
15
(6)
:486
.
(30 June 2026)
Efficacy and safety of combined RANKL and PD-1 inhibitors in bone metastases: a retrospective study
Translational Cancer Research
2026;
15
(6)
:487
.
(30 June 2026)
Multi-omics identification of an antibody dependent cellular phagocytosis related signature for hepatocellular carcinoma
Translational Cancer Research
2026;
15
(6)
:488
.
(30 June 2026)
Development and validation of a predictive model for perioperative venous thromboembolism in colorectal cancer patients based on D-dimer combined with fibrinogen levels
Translational Cancer Research
2026;
15
(6)
:489
.
(30 June 2026)
A senescence-based machine learning model prognosticates and personalizes therapy in cervical cancer
Translational Cancer Research
2026;
15
(6)
:490
.
(30 June 2026)
Association between pan-immune-inflammation value and prognosis in lung cancer patients: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:491
.
(30 June 2026)
Comparative effectiveness of immune checkpoint inhibitors in squamous vs. non-squamous cervical carcinoma: a systematic review and meta-analysis of randomized controlled trials
Translational Cancer Research
2026;
15
(6)
:492
.
(30 June 2026)
Comprehensive bioinformatics analysis identifies DNA methylation signatures associated with immune evasion and predicts immunotherapy response in breast cancer
Translational Cancer Research
2026;
15
(6)
:493
.
(30 June 2026)
Predictive value of the preoperative systemic immune-inflammation index for primary chemotherapy resistance risk in patients with advanced gastric cancer
Translational Cancer Research
2026;
15
(6)
:494
.
(30 June 2026)
Venous thromboembolism risk in sarcoma patients receiving combined immune checkpoint inhibitors and VEGF pathway inhibitors: a real-world cohort study
Translational Cancer Research
2026;
15
(6)
:495
.
(30 June 2026)
A mitochondrial function-based prognostic model for hepatocellular carcinoma uncovers MRPS15 as a key driver of tumor progression through oxidative phosphorylation
Translational Cancer Research
2026;
15
(6)
:496
.
(30 June 2026)
Spatial immune profiling of local tissues and its correlation with peripheral blood cytokines in lung squamous cell carcinoma patients with immune-related pneumonitis
Translational Cancer Research
2026;
15
(6)
:497
.
(30 June 2026)
A pneumolysin mutant (ΔA146 ply) induces pyroptosis in triple-negative and HER2-positive breast cancer cells via the Caspase-1/GSDME pathway: a potential antibody-drug conjugate payload
Translational Cancer Research
2026;
15
(6)
:498
.
(30 June 2026)
Single-cell mitophagy patterns dictate intercellular crosstalk in the tumor microenvironment to promote osteosarcoma progression
Translational Cancer Research
2026;
15
(6)
:499
.
(30 June 2026)
Tumor-derived CCL20 activates tumor-associated neutrophils, predicting good prognosis in endometrial cancer
Translational Cancer Research
2026;
15
(6)
:500
.
(30 June 2026)
Accuracy of machine learning in detecting lymph node metastasis of esophageal cancer: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:501
.
(30 June 2026)
Exosome-mediated regulation of the immune microenvironment via JAK/STAT signaling promotes pancreatic cancer progression
Translational Cancer Research
2026;
15
(6)
:502
.
(30 June 2026)
CNTN-1 regulates malignant biological behaviors of lung squamous cell carcinoma (LUSC) via the endoplasmic reticulum stress (ERS)/epithelial-mesenchymal transition (EMT) axis
Translational Cancer Research
2026;
15
(6)
:503
.
(30 June 2026)
Low-dose radiotherapy combined with immune checkpoint inhibitors in advanced malignancies: a real-world exploratory study
Translational Cancer Research
2026;
15
(6)
:504
.
(30 June 2026)
Expression profiling, molecular subtyping and prognostic signature construction of chemokines and chemokine receptors in gastric cancer
Translational Cancer Research
2026;
15
(6)
:505
.
(30 June 2026)
A nomogram based on systemic inflammatory markers: development and validation for predicting postoperative overall survival in gastric cancer
Translational Cancer Research
2026;
15
(6)
:506
.
(30 June 2026)
Review Article
Mitochondrial dynamics imbalance in hepatocellular carcinoma: from molecular mechanisms to new strategies for targeted therapy
Translational Cancer Research
2026;
15
(6)
:507
.
(30 June 2026)
Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Translational Cancer Research
2026;
15
(6)
:508
.
(30 June 2026)
Micro- and nanoplastic exposure and cancer: current evidence, mechanistic pathways, and translational challenges
Translational Cancer Research
2026;
15
(6)
:509
.
(30 June 2026)
Letter to the Editor
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trial
Translational Cancer Research
2026;
15
(6)
:510
.
(30 June 2026)
Erratum
Erratum: Evaluation of parietal pleural invasion in subpleural lung cancer by VEGFR2-targeted microbubble-based ultrasound molecular imaging
Translational Cancer Research
2026;
15
(6)
:511
.
(30 June 2026)
Erratum: Developing a prognostic risk model based on circulating tumor cell genes to predict prognosis and provide potential therapeutic strategies in colorectal cancer
Translational Cancer Research
2026;
15
(6)
:512
.
(30 June 2026)
